CClinicalTrials.gg
Sign In
Not yet recruitingNCT07497672Updated Apr 1, 2026

Evaluation of Novel Spectacles Intended for Myopia Management in a Short-Term Study

An interventional study of Habitual myopia glasses and Myopia Glasses A in Myopia: Refractive Error, sponsored by Myoptechs, Inc. Not yet recruiting. Open to participants aged 8 Years to 15 Years. Per ClinicalTrials.gov, last updated 2026-04-01.

Sponsored by Myoptechs, Inc · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
8 Years to 15 Years
Sex
All
01

Study summary

The primary objective of this study is to evaluate the visual acuity, wearability, and quality of vision with two novel multifocal glasses designs in habitual myopia control glasses wearers, in a non-dispensing study after short-term wear.

02

Conditions studied

  • Myopia: Refractive Error
03

In context

Lead sponsor

Myoptechs, Inc is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. 8 - 15 years of age, inclusive.
  2. Ability of the child to assent, and for one parent to provide permission to participate.
  3. Had an eye examination within the past year.
  4. Distance visual acuity of 20/25 (logMAR +0.10) or better in each eye with best corrected with sph/cyl subjective refraction.
  5. Habitual glasses wearer of either MiYOSMART or Stellest for at least 2 months. (Can also be a contact lens wearer but needs to wear either MiYOSMART or Stellest spectacles for a minimum of 6 hours on a typical day.)
  6. No history of binocular function anomaly (e.g., no history of strabismus), and no apparent strabismus.
  7. Good general health (defined by medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data, as determined by the investigator).

Exclusion criteria

Exclusion Criteria:

  1. Current report of active ocular inflammation or infection.
  2. Astigmatism > 1.00 D in either eye
  3. History of previous eye surgery
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
20 participants (estimated)

Study arms

  • Active comparator
    Habitual myopia glasses

    Device: Habitual myopia glasses

  • Experimental
    Myopia Glasses A

    Device: Myopia Glasses A

  • Experimental
    Myopia Glasses B

    Device: Myopia Glasses B

Interventions

  • DeviceHabitual myopia glasses

    Habitual myopia glasses of study P/905/25/MO

  • DeviceMyopia Glasses A

    Myopia glasses A of study P/905/25/MO

  • DeviceMyopia Glasses B

    Myopia glasses B of study P/905/25/MO

06

What researchers measure

Primary outcomes

  1. Binocular visual acuity

    Binocular visual acuity with habitual myopia spectacle lens design and two test spectacle lens designs.

    Time frame: 20 minutes of wearing each lens design.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — The results are regarded as confidential to our business as Sponsor, and confidential for the selection of one device to use in a future study. There are no plans for a public data repository for this study.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07497672
Lead sponsor
Myoptechs, Inc
Collaborators
University of Waterloo
Responsible party
Sponsor
First posted
Mar 27, 2026
Start date
Apr 15, 2026 (estimated)
Primary completion
Oct 15, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Apr 1, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Myoptechs, Inc

Start the discussion